Volume 13, Issue 3 (9-2025)                   JoMMID 2025, 13(3): 231-235 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Basak K, Gogoi A, Sabibahul Islam A K, Bora R. Stenotrophomonas maltophilia Infections in Infants: A Case Series from an Indian Neonatal and Pediatric Intensive Care Unit. JoMMID 2025; 13 (3) :231-235
URL: http://jommid.pasteur.ac.ir/article-1-662-en.html
Stenotrophomonas maltophilia Infections in Infants: A Case Series from an Indian Neonatal and Pediatric Intensive Care Unit
Kakali Basak * , Arpita Gogoi , Aukifa Khamim Sabibahul Islam , Reeta Bora
Department of Pediatrics, Assam Medical College and Hospital, Dibrugarh, Assam, India
Abstract:   (600 Views)
Introduction: Stenotrophomonas maltophilia, a Gram-negative, multidrug-resistant bacterium, is an emerging cause of hospital-acquired infections, particularly in immunocompromised pediatric patients. Its resistance to multiple antibiotics complicates therapeutic management, contributing to significant morbidity and mortality. This case series examines the risk factors and management strategies for S. maltophilia infections in a Neonatal and Pediatric Intensive Care Unit (NICU/PICU). Methods: A retrospective case series was conducted involving four infants (aged 1–4 months) admitted to the NICU or PICU at a tertiary care hospital in upper Assam, India, from January to December 2023. Clinical data, risk factors, antibiotic susceptibility, treatments, and outcomes were analyzed with parental consent. Results: All patients presented with sepsis, three with pneumonia and two with suspected meningitis. Risk factors included prematurity (n=2), low birth weight (n=2), mechanical ventilation (n=2), and prior antibiotic exposure (n=4). Blood cultures confirmed S. maltophilia, resistant to empirical antibiotics (ciprofloxacin, gentamicin) but isolates were susceptible to levofloxacin (n=4) and minocycline (n=4); two were also susceptible to trimethoprim-sulfamethoxazole (TMP-SMX) (n=2). Treatment with levofloxacin (14–21 days; n=3) or oral TMP-SMX (10 days; n=1) resulted in recovery in three patients with minimal residual sequelae. One patient died post-discharge after being readmitted for severe respiratory distress; the definitive cause of death was unknown. Conclusion: Tailored antibiotic therapy guided by susceptibility testing was associated with improved outcomes in S. maltophilia infections, despite multidrug resistance. Prematurity and mechanical ventilation were identified as key risk factors, highlighting the need for infection control and judicious antibiotic use.
Keywords: Stenotrophomonas maltophilia, Multidrug-resistant infections, Neonates, NICU/PICU, Antibiotic resistance, Sepsis
Full-Text [PDF 886 kb]   (95 Downloads)    
Type of Study: Case Report | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2024/04/12 | Accepted: 2025/09/10 | Published: 2025/12/2
References
1. Said MS, Tirthani E, Lesho E. Stenotrophomonas maltophilia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [cited 18 Jun 2024]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572123/
2. Bilen NM, Bal ZS, Özenen GG, Arslan SY, Ozek G, Karadas NO, et al. Risk factors for infection and mortality associated with Stenotrophomonas maltophilia bloodstream infections in children. Pediatr Infect Dis J. 2023; 42 (5): 374-80. [DOI:10.1097/INF.0000000000003845] [PMID]
3. Furuichi M, Ito K, Miyairi I. Characteristics of Stenotrophomonas maltophilia bacteremia in children. Pediatr Int. 2016; 58 (2): 113-8. [DOI:10.1111/ped.12745] [PMID]
4. Arthur C, Tang X, Romero JR, Gossett JG, Harik N, Prodhan P. Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience. Pediatr Cardiol. 2015; 36 (3): 509-15. [DOI:10.1007/s00246-014-1041-0] [PMID]
5. Latzer IT, Paret G, Rubinstein M, Keller N, Barkai G, Pessach IM. Management of Stenotrophomonas maltophilia infections in critically ill children. Pediatr Infect Dis J. 2018; 37 (10): 981-6. [DOI:10.1097/INF.0000000000001959] [PMID]
6. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998; 11 (1): 57-80. [DOI:10.1128/CMR.11.1.57] [PMID] [PMCID]
7. Rojas P, Garcia E, Calderón GM, Ferreira F, Rosso M. Successful treatment of Stenotrophomonas maltophilia meningitis in a preterm baby boy: a case report. J Med Case Rep. 2009; 3: 7389. [DOI:10.4076/1752-1947-3-7389] [PMID] [PMCID]
8. Chaudhari S, Suryawanshi P, Ambardekar S, Chinchwadkar M, Kinare A. Safety profile of ciprofloxacin used for neonatal septicemia. Indian Pediatr. 2004; 41 (12): 1246-51.
9. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr. 1979; 95 (1): 89-98. [DOI:10.1016/S0022-3476(79)80096-7] [PMID]
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2023.
11. Mouzinho A, Rosenfeld CR, Sánchez PJ, Risser R. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics. 1994; 94 (1): 76-82.
12. Ministry of Health and Family Welfare, Government of India. Integrated management of neonatal and childhood illness (IMNCI): participant module for health workers [Internet]. New Delhi: Ministry of Health and Family Welfare; 2023 [cited 2025 Apr 27]. Available from: https://nhm.gov.in/images/pdf/programmes/child-health/guidelines/IMNCI-Module-2023-For-health-worker/IMNCI-Participants-Module-Health-Workers-2023.pdf
13. Aygun AD, Akarsu S, Kilic M, Ozdiller S, Toprakli I. Purpura fulminans due to Stenotrophomonas maltophilia infection in a premature infant. Pediatr Int. 2006; 48 (3): 346-8. [DOI:10.1111/j.1442-200X.2006.02219.x] [PMID]
14. Viswanathan R, Singh AK, Ghosh C, Basu S. Stenotrophomonas maltophilia causing early onset neonatal sepsis. Indian Pediatr. 2011; 48 (5): 397-9. [DOI:10.1007/s13312-011-0063-4] [PMID]
15. Verweij PE, Meis JF, Christmann V, Van der Bor M, Melchers WJ, Hilderink BG, et al. Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water. Epidemiol Infect. 1998; 120 (3): 251-6. [DOI:10.1017/S0950268898008735] [PMID] [PMCID]
16. Ritchie DJ, Garavaglia-Wilson A. A Review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections. Clin Infect Dis. 2014; 59 (suppl 6): S374-80. [DOI:10.1093/cid/ciu613] [PMID]
17. Newby BD, Timberlake KE, Lepp ML, Mihic T, Tamara M, Dersch-Mills DA. Levofloxacin use in the neonate: a case series. J Pediatr Pharmacol Ther. 2017; 22 (4): 304-13. [DOI:10.5863/1551-6776-22.4.304] [PMID] [PMCID]
18. Jacob A, Iyadurai R, Punitha JV, Chacko B, Jasmine S, Bharathy M, et al. Stenotrophomonas isolates in a tertiary care centre in South India. Indian J Med Microbiol. 2022; 40 (1): 46-50. [DOI:10.1016/j.ijmmb.2021.11.004] [PMID]
19. Gulcan H, Kuzucu C, Durmaz R. Nosocomial Stenotrophomonas maltophilia cross-infection: three cases in newborns. Am J Infect Control. 2004; 32 (6): 365-8. [DOI:10.1016/j.ajic.2004.07.003] [PMID]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.